Univariate Cox analysis
| HR (95% CI for HR) | P value | |
| DOAC use | 9.6 (3.1 to 29) | 0.000069 |
| Extracardiac arteriopathy | 6.9 (2.6 to 18) | 0.000097 |
| Abdominal aneurysm | 5 (1.9 to 13) | 0.0011 |
| Angiotensin II receptor blocker use | 4.3 (1.7 to 11) | 0.0015 |
| Arrhythmia | 4.1 (1.7 to 10) | 0.0023 |
| Diabetes on insulin | 3.6 (0.84 to 16) | 0.084 |
| Previous PCI | 3.2 (1.2 to 9) | 0.025 |
| Heparin use | 3.2 (1.2 to 8.9) | 0.026 |
| Calicium antagonist use | 2.9 (1.1 to 7.6) | 0.031 |
| Other platelet inhibiting drugs | 3.1 (1.2 to 8.1) | 0.023 |
| History of severe ventricular arrhythmia | 3.1 (1.2 to 8.1) | 0.023 |
| ACE inhibitor use | 2.5 (0.83 to 7.6) | 0.1 |
| Recent myocardial infarction | 2.5 (0.82 to 7.4) | 0.11 |
| Previous myocardial infarction | 2.2 (0.79 to 6.1) | 0.13 |
| Diabetes without insulin | 2.1 (0.61 to 7.2) | 0.24 |
| Chronic pulmonary disease | 2.1 (0.78 to 5.4) | 0.15 |
| Thoracic aneurysm | 1.9 (0.65 to 5.9) | 0.24 |
| Critical preoperative state | 2 (0.65 to 5.9) | 0.23 |
| Nitrate use | 1.9 (0.56 to 6.6) | 0.3 |
| Renal failure | 1.9 (0.64 to 5.8) | 0.24 |
| Hypertension | 1.8 (0.67 to 5.1) | 0.24 |
| Beta blocker use | 1.7 (0.64 to 4.5) | 0.29 |
| Age | 1 (0.99 to 1.1) | 0.15 |
DOAC, direct oral anticoagulants ; PCI, Percutaneous coronary intervention.